ISG CONTROL OF FLAVIVIRUS INFECTION

ISG 控制黄病毒感染

基本信息

  • 批准号:
    8601427
  • 负责人:
  • 金额:
    $ 61.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-01-01 至 2017-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Members of Flavivirus genus are the most important arthropod-borne viruses causing disease in humans. This genus includes viruses (West Nile virus (WNV), Japanese encephalitis virus (JEV) and Dengue virus (DENV)) that are re-emerging and becoming endemic in new areas of the world. Flaviviruses account for ~100 millions infections per year, with billions at risk and no specific therapy available. Although interferon (IFN) responses control the cell and tissue tropism of WNV and other flaviviruses, the specific effector molecules that restrict infection remain poorly characterized. The studies in this collaborative and inter-disciplinary project between the Diamond and Chanda laboratories will use genetic screens to identify novel interferon stimulated genes (ISG) that modulate flavivirus infection in specific cell types ex vivo and in vivo. Loss-of-function high-throughput genetic screens will be performed with a custom- generated GFP-marked shRNA library targeting ~700 mouse and human ISGs, to identify novel ISG that restrict infection of virulent and attenuated strains of WNV. Using stable cell lines that have targeted reductions or ectopic expression of candidate ISGs, we will define mechanistically how novel ISG effector molecules restrict specific steps in the viral lifecycle and influence infection outcome. In preliminary studies, we have identified several candidate inhibitory ISG (Ifi27, IFIT2, and IFITM3) that attenuate WNV infection, and already acquired or generated knockout mice. Using these mice, we will evaluate the function of these particular ISGs in restricting WNV replication in a cell-specific manner and in vivo. We hypothesize that specific ISGs have antiviral properties that differentially control WNV infection and spread, and that these demonstrate tissue and cell-type specificity. Overall, these experiments will more clearly define the interface between IFN control and flavivirus pathogenesis and possibly, guide strategies that modulate immunity to infection by this family of viruses.
描述(由申请方提供):黄病毒属成员是引起人类疾病的最重要的节肢动物传播病毒。该属包括病毒(西尼罗河病毒(WNV)、日本脑炎病毒(JEV)和登革热病毒(DENV)),这些病毒在世界新地区重新出现并成为地方病。黄病毒每年造成约1亿例感染,数十亿人处于危险之中,并且没有特定的治疗方法。虽然干扰素(IFN)的反应控制的细胞和组织嗜性的西尼罗河病毒和其他黄病毒,限制感染的特定效应分子仍然很差的特点。Diamond和Chanda实验室之间的这项合作和跨学科项目中的研究将使用遗传筛选来鉴定新型干扰素刺激基因(ISG),这些基因在体外和体内调节特定细胞类型中的黄病毒感染。将使用定制生成的GFP标记的shRNA文库(靶向约700个小鼠和人ISG)进行功能丧失高通量遗传筛选,以鉴定限制WNV强毒株和减毒株感染的新型ISG。使用具有候选ISG的靶向减少或异位表达的稳定细胞系,我们将从机制上定义新型ISG效应分子如何限制病毒生命周期中的特定步骤并影响感染结果。在初步研究中,我们已经鉴定了几种减弱WNV感染的候选抑制性ISG(IFi27、IFIT2和IFITM3),并且已经获得或产生敲除小鼠。使用这些小鼠,我们将评估这些特定的ISG在限制WNV复制的细胞特异性方式和体内的功能。我们假设特异性ISGs具有差异控制西尼罗河病毒感染和传播的抗病毒特性,并且这些表现出组织和细胞类型特异性。总体而言,这些实验将更清楚地定义IFN控制和黄病毒发病机制之间的接口,并可能,指导策略,调节免疫力感染这一家族的病毒。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUMIT K CHANDA其他文献

SUMIT K CHANDA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUMIT K CHANDA', 18)}}的其他基金

Determinants of HIV-1 innate immune sensing and its role in shaping the lymphoid environment.
HIV-1 先天免疫感应的决定因素及其在塑造淋巴环境中的作用。
  • 批准号:
    10712594
  • 财政年份:
    2023
  • 资助金额:
    $ 61.32万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10514318
  • 财政年份:
    2022
  • 资助金额:
    $ 61.32万
  • 项目类别:
Center for Antiviral Medicines & Pandemic Preparedness (CAMPP)
抗病毒药物中心
  • 批准号:
    10514317
  • 财政年份:
    2022
  • 资助金额:
    $ 61.32万
  • 项目类别:
Reversing Immune Dysfunction for HIV-1 Eradication
逆转免疫功能障碍以根除 HIV-1
  • 批准号:
    10469447
  • 财政年份:
    2021
  • 资助金额:
    $ 61.32万
  • 项目类别:
Reversing Immune Dysfunction for HIV-1 Eradication
逆转免疫功能障碍以根除 HIV-1
  • 批准号:
    10313784
  • 财政年份:
    2021
  • 资助金额:
    $ 61.32万
  • 项目类别:
Reversing Immune Dysfunction for HIV-1 Eradication
逆转免疫功能障碍以根除 HIV-1
  • 批准号:
    10540209
  • 财政年份:
    2021
  • 资助金额:
    $ 61.32万
  • 项目类别:
Project 2 - Host-virus networks regulating flu replication and host responses ex vivo
项目 2 - 调节流感复制和宿主离体反应的宿主病毒网络
  • 批准号:
    10080715
  • 财政年份:
    2018
  • 资助金额:
    $ 61.32万
  • 项目类别:
Early development of small molecule dendritic cell immunopotentiators for the treatment of solid tumors
用于治疗实体瘤的小分子树突状细胞免疫增强剂的早期开发
  • 批准号:
    10180915
  • 财政年份:
    2018
  • 资助金额:
    $ 61.32万
  • 项目类别:
A Novel Conformation of the ZIKV Protease Provides a Unique 3D Scaffold for Discovering Allosteric Protease Inhibitors as Direct Anti-virals, via HT and Virtual Screening, and Protein Engineering
ZIKV 蛋白酶的新颖构象为通过 HT 和虚拟筛选以及蛋白质工程发现变构蛋白酶抑制剂作为直接抗病毒药物提供了独特的 3D 支架
  • 批准号:
    9757689
  • 财政年份:
    2018
  • 资助金额:
    $ 61.32万
  • 项目类别:
Project 2 - Host-virus networks regulating flu replication and host responses ex vivo
项目 2 - 调节流感复制和宿主离体反应的宿主病毒网络
  • 批准号:
    10322693
  • 财政年份:
    2018
  • 资助金额:
    $ 61.32万
  • 项目类别:

相似海外基金

RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 61.32万
  • 项目类别:
    Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 61.32万
  • 项目类别:
    Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.32万
  • 项目类别:
    Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.32万
  • 项目类别:
    Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.32万
  • 项目类别:
    Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 61.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 61.32万
  • 项目类别:
    Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
  • 批准号:
    2301846
  • 财政年份:
    2023
  • 资助金额:
    $ 61.32万
  • 项目类别:
    Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 61.32万
  • 项目类别:
    Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
  • 批准号:
    23K16076
  • 财政年份:
    2023
  • 资助金额:
    $ 61.32万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了